CRIS vs ANRO

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 09, 2026

CRIS

31.4
AI Score
VS
ANRO Wins

ANRO

44.9
AI Score

Investment Advisor Scores

CRIS

31score
Recommendation
SELL

ANRO

45score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric CRIS ANRO Winner
Net Income -7.58M -53.88M CRIS
Operating Income -5.71M -56.27M CRIS
ROE -138.8% -24.6% ANRO
ROA -38.0% -21.2% ANRO
Total Assets 19.97M 254.07M ANRO
Cash 5.06M 243.73M ANRO
Current Ratio 0.49 14.85 ANRO

Relative Price Performance (Last 90 Days)

CRIS 1M: -12.4% · 3M: -75.3% ANRO 1M: +30.6% · 3M: -12.1%

Current Technical Phase

CRIS

Markdown
Sell / avoid

Price below a falling SMA50 (slope -40.0%), weak momentum, RSI 38

RSI (14): 38.0 · Price: $0.45

ANRO

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 64

RSI (14): 63.7 · Price: $29.54

Fundamentals Snapshot

Metric CRIS ANRO
Market Cap — —
Forward P/E -0.1 -14.8
Trailing P/E 0.4 —
Revenue (TTM) — —
Revenue Growth -0.7% 0.0%
Gross Margin -4.9% —
Operating Margin -8.3% 0.0%
EPS 1.32 -2.32
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, ANRO is currently the stronger investment candidate, winning 5 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.